EWEdwards Lifesciences Corpvs its industry peers
A metric-by-metric comparison of Edwards Lifesciences Corp against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EWThis | $51.5B#16 | 51.9x#13 | 4.8x#6 | 8.5x#13 | 11.5%#4 | -74.3%#16 | 20.8%#10 | 10.1%#12 | 12.6%#10 | 6#2 | 18.9%#11 | — |
| LLY | $1.07T#1 | 38.2x#11 | 31.6x#15 | 16.4x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 60.9%#3 | 26.3%#2 | — | 49.7%#3 | 0.5%#12 |
| JNJ | $644.2B#2 | 31.0x#7 | 7.6x#10 | 6.8x#11 | 6.0%#9 | 90.6%#5 | 22.9%#8 | 31.5%#7 | 16.1%#7 | 6#2 | 54.4%#2 | 1.9%#10 |
| ABBV | $464.0B#3 | 74.2x#14 | — | 7.6x#12 | 8.6%#7 | -1.2%#10 | 24.6%#7 | — | 18.6%#6 | — | 24.5%#9 | 2.5%#5 |
| UNH | $336.9B#5 | 24.1x#3 | 10.2x#12 | 0.8x#2 | 11.8%#3 | -16.3%#13 | 4.2%#15 | 36.5%#5 | 21.3%#5 | — | 13.1%#12 | 2.3%#6 |
| MRK | $357.5B#4 | 115.9x#15 | 8.5x#11 | 5.5x#7 | 1.3%#14 | 6.6%#8 | 34.2%#3 | 43.5%#4 | 21.6%#4 | — | 82.8%#1 | 2.3%#8 |
| AMGN | $203.5B#7 | 23.4x#2 | 17.4x#14 | 5.5x#8 | 10.0%#5 | 88.5%#6 | 24.7%#6 | 66.0%#2 | 15.1%#8 | — | 41.3%#4 | 2.5%#4 |
| TMO | $239.8B#6 | 34.9x#8 | 4.6x#5 | 5.4x#6 | 3.9%#11 | 6.0%#9 | 17.4%#13 | 12.8%#10 | 10.1%#11 | — | 35.2%#6 | 0.3%#13 |
| ABT | $178.3B#9 | 28.7x#5 | 3.4x#4 | 4.0x#5 | 5.7%#10 | -51.3%#14 | 18.2%#12 | 12.5%#11 | 8.3%#12 | — | -21.1%#14 | 2.3%#7 |
| GILD | $183.2B#8 | — | 15.5x#13 | 6.2x#10 | 2.4%#13 | 1672.9%#1 | 34.0%#4 | 71.9%#1 | 26.7%#1 | — | 36.2%#5 | 2.2%#9 |
| ISRG | $135.1B#12 | 43.8x#12 | 7.4x#9 | 13.4x#15 | 20.5%#2 | 23.0%#7 | 29.3%#5 | 15.7%#9 | — | — | -12.0%#13 | — |
| PFE | $156.7B#10 | 36.2x#9 | 1.8x#2 | 2.5x#3 | -1.6%#16 | -3.2%#11 | 16.3%#14 | 9.1%#13 | 6.9%#13 | — | 22.3%#10 | 6.2%#1 |
| CVS | $117.3B#15 | 24.2x#4 | 1.5x#1 | 0.3x#1 | 7.8%#8 | -61.7%#15 | 1.2%#16 | 2.2%#15 | 2.9%#15 | 6#2 | 28.4%#8 | 2.9%#3 |
| VRTX | $130.0B#13 | 29.9x#6 | 6.4x#8 | 10.8x#14 | 8.9%#6 | 838.1%#2 | 34.8%#2 | 19.5%#8 | 25.0%#3 | — | 31.1%#7 | — |
| DHR | $146.5B#11 | 37.0x#10 | 2.8x#3 | 6.0x#9 | 2.9%#12 | -7.3%#12 | 19.1%#11 | 6.9%#14 | 5.4%#14 | 5#5 | — | 0.6%#11 |
| BMY | $129.9B#14 | 14.0x#1 | 5.8x#7 | 2.7x#4 | -0.2%#15 | 178.8%#3 | 21.8%#9 | 31.6%#6 | 14.0%#9 | 7#1 | — | 3.9%#2 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice